CClinicalTrials.gg
CompletedNCT04890080Updated May 18, 2021

Resting Heart Rate in Chronic Obstructive Pulmonary Disease

An interventional study of Pulmonary Rehabilitation in Pulmonary Rehabilitation, Exercise and COPD, sponsored by Izmir Katip Celebi University. Completed. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-05-18.

Sponsored by Izmir Katip Celebi University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 4 years 4 months after the study started (first participant enrolled Jan 2017, registered May 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
110
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

110 COPD patients who were participated in the PR program were included in the study. Resting Heart Rate , pulmonary functions, functional capacity, perception of dyspnea, quality of life and psychological symptoms compared before and after PR.

Read the detailed description

In many studies, it has been reported that baroreceptor activity and heart rate variability decrease and resting heart rate (RHR) increases in COPD patients due to changes in cardiac autonomic function. Among the recommendations regarding pulmonary rehabilitation (PR) and exercise training in COPD patients, approaches such as including practices targeting RHR and developing implementation strategies that improve the cardiovascular system are recommended. The primary aim of our study is to examine the effect of comprehensive exercise training consisting of breathing, aerobic and strengthening exercises on RHR in COPD patients, and secondarily to determine the factors that affect RHR change after PR in COPD patients.

110 COPD patients who were participated in the PR program were included in our retrospective study. Resting Heart Rate , pulmonary functions, functional capacity, perception of dyspnea, quality of life and psychological symptoms compared before and after PR.

02

Conditions studied

  • Pulmonary Rehabilitation
  • Exercise
  • COPD
  • Resting Heart Rate

Keywords

  • resting heart rate
  • COPD
  • exercise
  • pulmonary rehabilitation
03

In context

Lung Diseases, Obstructive

2,592 studies on the registry are indexed under Lung Diseases, Obstructive; 198 are open to participants now.

This study's enrollment of 110 is above the median of 66 across 1,837 interventional studies indexed under Lung Diseases, Obstructive.

Browse Lung Diseases, Obstructive studies →

Lead sponsor

Izmir Katip Celebi University is the lead sponsor of 191 studies on the registry; 40 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients diagnosed with COPD according to GOLD and completed the 2-day / 8-week PR program

Exclusion criteria

Exclusion Criteria:

  • With cardiovascular disease
  • With additional diseases such as diabetes
  • Receiving medical treatment that affects the autonomic nervous system
  • Patients receiving long-term oxygen therapy
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
110 participants (actual)

Study arms

  • Experimental
    PR Group

    Patients diagnosed with COPD according to GOLD and completed the 2-day / 8-week PR program

    Other: Pulmonary Rehabilitation

Interventions

  • OtherPulmonary Rehabilitation

    Exercise training consisted of supervised breathing, aerobic, strengthening and stretching exercises for 8 weeks, 2 days a week. Breathing exercises included pursed lip, diaphragmatic, thoracic expansion and basal expansion exercises. Strength training included the lower and upper extremities, and it was performed 8-10 repetitions, either against gravity or using free weight, according to patient tolerance.

06

What researchers measure

Primary outcomes

  1. Resting Heart Rate

    number of beats per minute

    Time frame: 1 minute

Secondary outcomes

  1. Functional Capacity

    Six Minute- walk test

    Time frame: Change from baseline six minute walk distance at 8 week

  2. Dyspnea Assessment

    Medical Research Council Scale(MRC); the MRC dyspnea scale is a questionnaire that consists of five statements about perceived breathlessness. (min 1- max 5 point) Higher scores mean a worse outcome.

    Time frame: Change from baseline dyspnea at 8 week

  3. Quality of Life Assessment

    St. George Respiratory Questionnaire; Scores range from 0 to 100, with higher scores indicating more limitations.

    Time frame: Change from baseline dyspnea at 8 week

  4. Anxiety and Depression

    Hospital Anxiety and Depression (HAD); The HADS questionnaire has seven items each for depression and anxiety subscales. Scoring for each item ranges from zero to three, with three denoting highest anxiety or depression level. A total subscale score of \>8 points out of a possible 21 denotes considerable symptoms of anxiety or depression.

    Time frame: Change from baseline dyspnea at 8 week

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 18, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04890080
Lead sponsor
Izmir Katip Celebi University
Responsible party
Ilknur Naz (Assoc. Prof., Izmir Katip Celebi University) — Principal investigator
First posted
May 18, 2021
Start date
Jan 2017
Primary completion
Dec 2019
Completion
Apr 2021
Last update
May 18, 2021

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion